Nanox (NASDAQ: NNOX) has entered into a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement positions Nanox to penetrate a new market in Latin America, following similar moves in Argentina and Peru this year, as part of its broader strategy to drive the world's transition to preventive health care.
Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. This relationship could facilitate adoption of the Nanox.ARC within Costa Rica's public healthcare system, potentially accelerating the technology's integration into routine care.
Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. This stepwise approach allows for clinical validation and adaptation to local requirements, which is critical for building trust and demonstrating the system's efficacy in diverse healthcare settings. Success in Costa Rica could serve as a model for other markets with similar regulatory and infrastructural characteristics.
The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. It is part of the Nanox ecosystem, which includes Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The Costa Rica agreement represents a tangible step toward expanding the reach of medical imaging both within and beyond traditional hospital settings, particularly in regions where access to advanced diagnostic tools is limited.
For investors, this announcement signals Nanox's continued commitment to international expansion, which could drive revenue growth and diversify its market base. For healthcare providers in Costa Rica, the availability of the Nanox.ARC may enhance diagnostic capabilities, enabling earlier detection of diseases and improving patient outcomes. The partnership with SOLME, a local distributor with established ties to the CCSS, increases the likelihood of successful adoption and long-term sustainability.
To view the full press release, visit https://ibn.fm/C77lJ. The latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX. Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: https://IBN.ai/Disclaimer.
